Quicklinks

Home > About Us > Pathologists

Professor Paul N Goldwater

Qualifications:BSc (Hon) MBBS, FRACP, FRCPA
Practice Responsibilities: Consultant in Clinical Microbiology and Infectious Diseases, Public Health Department (WCH site)
Specialities: Clinical virology adolescent and maternofetal infection
Phone: 08 8161 7432
Email:
Site(s): WCH
Division: Microbiology and Infectious Diseases

Professor Paul Goldwater undertook undergraduate training in microbiology and medicine at the University of Surrey (1968) and The London Hospital Medical College (1973), respectively.  His postgraduate training was in infectious diseases, microbiology and virology at Auckland Hospital, N.Z. and St. Thomas’ Hospital, London.

Since 1986, he has been Senior Consultant Clinical Microbiologist/Infectious Diseases Physician at the Adelaide Children’s Hospital/The Women’s and Children’s Hospital, Children, Youth and Women’s Health Service and now the IMVS.  He is responsible for running the Infectious Diseases Outpatient Clinic and has a special interest in HIV infection in pregnancy and in children, and the prevention of maternofetal transmission of blood borne viruses.

Professor Goldwater’s present research interests include the role of toxigenic bacteria and viruses in the pathogenesis of sudden infant death syndrome, the pathogenesis of cerebral palsy (principal investigator in the South Australian Cerebral Palsy Research Group), haemolytic uraemic syndrome (HUS), hepatitis B vaccine non-responsiveness, novel vaccine adjuvants, rapid diagnosis of infection, nosocomial infection and inoculation injury prevention.

He has conducted a number of randomised placebo-controlled trials and published 160 papers in international journals and one book on HIV/AIDS.

Show Publications +

Show Publications +

Publications

Original articles:

  1. Goldwater, PN, Foster,  JS. l976  Chronic  Chest Wall Sinus : An unusual presentation of typhoid. NZ Med J. 83: 116-117.
  2. Goldwater, PN, Laws, J.  1977.  Echovirus 19 outbreak in Auckland, 1975- 76. NZ Med J. 86: 319-322.
  3. Goldwater, PN, Quiney, JR,  Banatvala, JE. l978.  Maternal Rubella at St. Thomas’ Hospital.   Is there a need to change British vaccination policy?  Lancet 2:  1298-1300.
  4. Goldwater, PN. l979.  Gastroenteritis in Auckland: an aetiological and clinical study.  J. Infection. l: 339-35l.
  5. Goldwater, PN, Chrystie, IL, Banatvala, JE. l979.  Rotaviruses and the Respiratory Tract.  Brit. Med. J. 2: l55l.
  6. Goldwater, PN, Chrystie,  IL.  l979.  Retrieving  Specimen Holders. Proc. Roy. Microscopical Soc. 14: 374-376.
  7. Goldwater,  PN,  Banatvala,  JE.  l98l.   Solid-phase immunosorbent haemadsorption   (SPIHAD):  A  new,  rapid   and  simple  test  for rubella-specific IgM. J. Virol. Method. 2: 34l-347.
  8. Goldwater, PN, Webster,  M, Banatvala, JE.  l982.  Use of  a simple new test for virus-specific  IgM  to  investigate  an  outbreak  of influenza B  in a  hospitalised aged  community. J.Virol.Method 4: 9-l8.
  9. Goldwater, PN, Bettelheim, KA, Ellis-Pegler, RB. l98l.  Escherichia coli in  gastroenteritis of children in  Auckland, New Zealand.  J. Hyg. Camb. 87: 413-419.
  10. Goldwater, PN, Woodfield, DG, Anderson, RA, Gill, MB, Carpenter, S. l982.   Acute sporadic Non-A, non-B hepatitis in an urban community in New Zealand, Aust. N.Z.  J. Med. 12: 268-27l.
  11. Goldwater, PN, Woodfield, DG, Anderson, RA, Gill, MB, Carpenter, S. l982.   Acute sporadic Non-A, non-B hepatitis in Auckland. In Viral Diseases of South-East  Asia and the  Western Pacific, pp  40l-402. Ed J.S. Mackenzie, Academic Press, l982.
  12. Goldwater,  PN,  l982.  Markers  of  double infections (abstract in Hepatitis   B  in  New  Zealand,  Report  of  a  workshop  held  at Whakatane).   Published  by  the  Pathology  Laboratory, Whakatane Public Hospital.
  13. Goldwater, PN. l983.  The control of  hepatitis B in  the hospital setting.   The Dissector (The Journal of Theatre Nurses’ Section of NZNA) 10: 10-13.
  14. Goldwater, PN. l983.  Infectious mononucleosis: Current  Concepts, Recognition and Management.  September, 89-99.
  15. Goldwater, PN.  l984.  Acyclovir  (Guest Editorial),  New Ethicals. February, 9-11.
  16. Goldwater,  PN,  Ikin,  P.  Baguley,  BC.  l983.    Antiherpesvirus activity of AMSA  derivatives.   Proc.  Auckland  Medical  Research Club, NZ Med J. 96: 302
  17. Goldwater, PN,  Flynn, K.  Baguley, BC.  l984.  Anilinoacridines: A new class  of compound active against  Herpes Simplex virus.  Proc. Auckland Medical Research Club, NZ Med J. 97: 193.
  18. Goldwater,  PN,  Gunn,  C,  Flynn,  KE,  Baguley,  BC.  l985.  Can 9-anilinoacridines eliminate latent  herpes?   Herpes  Viruses  and Virus  Chemotherapy.  Pharmacological  and  Clinical Approaches. R. Kono, A. Nakajima, Eds.  Excerpta  Medica.  International  Congress Series 667, P.243-246.
  19. Goldwater, PN, l984.  Antiviral Drugs Today.  Editorial NZ Med.  J. 97: 852-854.
  20. Goldwater, PN.  l984.  Hepatitis  B vaccine.  Cost-effective use in the hospital setting.  Guest editorial Hospital Therapeutics l (l): 5-9.
  21. Goldwater, PN.  l985.  Viral  Hepatitis  Identified II: Active or Passive Immunization?  Patient Management, l4: 37-48.
  22. Goldwater, PN.  l985.   Hepatitis B Review. New  Zealand Microbiological Society Newsletter, February, 12-15.
  23. Goldwater,   PN,   Flynn,   KE,   Gunn,   CI,  Baguley,  BC.  9-anilinoacridines:  Novel compounds active  against herpes simplex virus.  Chemico-Biological Interactions. 66; 377-382.
  24. Goldwater,  PN,  Synek,  BJL,   Koelmeyer  TD,  Scott,  PJ.   l985. Structures resembling  scrapie-associated  fibrils  found  in  AIDS encephalopathy.   Lancet ii; 447-448.
  25. Goldwater, PN, Abbott, M.  (Editors).  Preventive Medicine and the Nuclear Arms Race.  Mental Health Foundation of New Zealand, l985.
  26. Gunn, CS, Goldwater, PN. l986.  An in vitro reactivation system for investigation  of Herpes Simplex virus latency.  J. Med. Virol. l8; 247-254.
  27. Buchanan,  JG,  Goldwater,  PN,  Somerfield,  SD,  Tobias, M. l986. Acute  HTLV-III-associated mononucleosis  syndrome. NZ  Med J  99 : 405-408.
  28. Goldwater,  PN.  l986.    DNA  Hybridization  in   Diagnosis. New Frontiers in Medicine.,Patient Management.l5 (l):74-78.
  29. Goldwater,  PN,  Woodfield,  DG,  Ramirez,  AM,  Steed,  I.   l986. Intradermal, Low Dose,  Short Course  Hepatitis B  Vaccination.  NZ Med J 99: 703-705.
  30. Nixon, AD, Law, R, Officer,  JA, Cleland, JF, Goldwater, PN.  l986. Simple  device to prevent accidental needle-prick injuries.  Lancet i: 888-889.
  31. Moyes, CD, Milne,  A, Dimitrakakis, M,  Goldwater, PN.  l987.  Very low dose  hepatitis B vaccine  in Neonates: an  economic option for hepatitis B control in endemic areas.  Lancet i : 29-31.
  32. Milne,  A,  Allwood,  G,  Campbell,  C,  Dimitrikakas, M, Lucas, R, Goldwater, PN,  Pearce N,  Krugman, S.  1987.  Low dose vaccination against  hepatitis  B:  one  year  follow  up.  J Med Virol. 22 : 387-392.
  33. Goldwater PN. l986.  Out of Africa. NZ Med J. 99 : 770.
  34. Goldwater PN. l986.  Scrapie-associated fibrils and AIDS encephalopathy.  Biomedicine & Pharmacotherapy.  40 : 424
  35. Lane MR, Hannon S, Woodfield DG, Goldwater PN, Lee SP. l987. Acute viral Hepatitis in Auckland. NZ Med J. l00: 99-102.
  36. Goldwater PN l987. Hepatitis  B Vaccination : Present  and Future. Hospital Therapeutics 28 (5) : 25-34.
  37. Goldwater PN  1987.  Hepatitis  B Vaccination : Present  and Future. Medical Progress l4 : 11-17.
  38. Goldwater PN.  1987.  Device to permit recapping of syringes without risk of infection.  Brit. Med. J. 295: 668.
  39. Goldwater PN.  1987.  AIDS - The need for appropriate  action.  The Needle l: 15-16.
  40. Goldwater PN,  Kernick  CG,  Martin  AJ, Delbridge RG, Matthews NT 1988.   False negative HIV serology in a case of congenital/perinatal AIDS.  Aust. Paediatr. J. 24 : 199-202.
  41. Goldwater, PN. 1988. Hepatitis B Vaccination.  The Physician India. 4(1) : 50-54.
  42. Goldwater PN, Paton JC.  1988.  Apparent non-involvement of  prions in  the pathogenesis  of spongiform  change in  HIV-infected brain. Journal of  Neuropathology and  Experimental Neurology.  1989; 48 : 184-186.
  43. Goldwater PN, Law R, Nixon AD, Officer JA, Cleland JF.  Impact of a recappping  device on  venepucture-related  needlestick  injury. Infect Control Hosp Epidemiol 1989; 10 : 21-25.
  44. Goldwater PN.  Occupational HIV risk. NZ  Med J 1989; 102: 231. (letter).
  45. Goldwater PN.  Exposure of health care workers to the blood of patients infected with the human immunodeficiency virus. New Engl J Med 1989; 320: 1350-1351.
  46. Goldwater PN.  A fresh look at the transmission of the human immunodeficiency virus.  Med J Australia 1989, 151 : 359-360.
  47. Bettleheim  KA,  Dwyer  BW,  Smith  DL,  Goldwater  PN,  Bourne AJ. Toxigenic Escherichia coli associated  with  sudden  infant  death syndrome.  Med J Australia, 1989; 151 : 538.
  48. Bettelheim  KA,  Goldwater  PN,  Dwyer  BW,  Bourne  AJ,  Smith DL. Toxigenic Escherichia coli associated  with  sudden  infant  death syndrome. Scand J Infect Dis 1990; 22: 467-476.
  49. Goldwater PN.  Aetiopathological correlation in the  sudden infant death syndrome. NZ Med J 1990; 102: 226.
  50. Goldwater PN, Williams V, Bourne AJ, Byard RW.  Sudden infant death syndrome : a possible clue to causation.  Med J Australia 1990; 153 : 59-60.
  51. Paton AW, Goldwater PN.  Respiratory Syncytial Virus modulation of adult and  neonatal lymphocyte mitogenic responses  and the role of interferon gamma. Microbial Pathogenesis 1990; 9: 235-241.
  52. Goldwater PN, Martin AJ, Ryan B, Morris S, Thompson J, Kok TW, Burrell CJ. A survey of nosocomial respiratory viral infections in a children’s hospital: Occult respiratory infection in patients admitted during an epidemic season. Infection Control and Hospital Epidemiology 1991; 12: 231-238.
  53. Goldwater PN. Preventing needlestick injuries. Brit Med J 1991; 302: 1602-1603 (letter).
  54. Bettelheim KA, Smith H, Goldwater PN, Morris JA, Murrell TGC, Sweet C, Weaver S. Sleeping position and cot deaths. Lancet 1991; 338: 192 (letter).
  55. Goldwater PN. Which antibiotic and when. Australian Family Physician. 1991; 20: 579-585.
  56. Bettelheim KA, Goldwater PN, Evangelidis H, Pearce JL, Smith DL. Distribution of toxigenic Escherichia coli serotypes in the intestines of infants. Comp Immun Microbiol Infect Dis 1992; 15: 65-70.
  57. Goldwater PN. Reappraisal of the SIDS enigma: An epidemiological and clinicopathogical approach. J Paediatr Child Health 1992; Suppl. 1, S21-25.
  58. Paton AW, Paton JC, Lawrence AJ, Goldwater PN, Harris RJ. Rapid detection of respiratory syncytial virus in nasopharyngeal apirates by reverse transcription and polymerase chain reaction amplification. J Clin Microbiol 1992; 30: 901-904.
  59. Byard RW, Moore L, Bourne AJ, Lawrence AJ, Goldwater PN. Clostridium botulinum and sudden infant death syndrome: A 10 year prospective study. J. Paediatr Child Health 1992; 28: 156-157.
  60. Goldwater P. Coxsackie B5 Cluster in Adelaide, September-October 1992. Communicable Disease Intelligence 1992; 16: 500.
  61. Bettelheim KA, Evangelidis H, Pearce JL, Goldwater PN, Luke RK. The isolation of cytotoxic necrotising factor (CNF)-producing Escherichia coli from the intestinal contents of babies who died of sudden infant death syndrome and other causes as well as from the faeces of healthy babies. Comp Immunol Microbiol Infect Dis 1992; 16: 87-90. 
  62. Smith PK, Goldwater PN. Kawasaki Disease in Adelaide: A Review. J Paediatr Child Health 1993; 29: 126-131.
  63. Byard RW, Bourne AJ, Matthews N, Roberton DM, Goldwater PN, Hansman D. Pulmonary strongyloidiasis in a child diagnosed on open lung biopsy. Surgical Pathology 1993; 5: 55-62.
  64. Paton AW, Paton JC, Goldwater PN, Heuzenroeder MW, Manning PA. Sequence of a variant Shiga-like toxin type-I operon of Escherichia coli O111:H- Gene 1993; 129: 87-92.
  65. Paton AW, Paton JC, Goldwater PN, Heuzenroeder MW, Manning PA. Cloning and nucleotide sequence of a variant Shiga-like toxin II gene from Escherichia coli OX3:H21 isolated from a case of sudden infant death syndrome. Microbial Pathogenesis 1992; 13: 225-236.
  66. Goldwater PN. Update: The immunization schedule. The Women’s and Children’s Hospital Clinical Quarterly. 1993; 6: 1-2. 
  67. Goldwater PN. History of hepatitis B vaccination in New Zealand: Lessons for Australia? Aust J Public Health 1993; 17: 221-225.
  68. Paton AW, Paton JC, Goldwater PN, Manning PA. Direct detection of Escherichia coli shiga-like toxin genes in primary fecal cultures using polymerase chain reaction. J Clin Microbiol 1993; 31: 3063-3067.           
  69. Goldwater PN. Randomised comparative trial of interferon-a versus placebo in hepatitis B vaccine non- and hypo-responders. Vaccine 1994; 12: 410-414.
  70. Bettelheim KA, Pearce JL, Evangelidis H, Goldwater PN. A mouse model for sudden infant death syndrome. Proc. Second SIDS Family International Conference, Sydney 1992. Perinatology Press, eds Walker AM, McMillen C. Ithica, NY, 1993. pp 121-123.
  71. Davis SR, Ellis DH, Goldwater PN, Dimitriou S, Byard R. First human culture-proven Australian case of entomophthoromycosis caused by Basidiobolus ranarum. J Med Vet Mycol 1994; 32: 225-230.
  72. Maxwell FC, Couper RTL, Morris LL, Goldwater PN, Hansman DJ. Meningitis and sphenoidal sinusitis associated with free gas in the suprasellar cistern. Pediatric Radiology 1994; 24:594-595.
  73. Goldwater PN and Bettelheim KA. 1994. The role of enterohaemorrhagic E. coli serotypes other than O157:H7 as causes of disease, p. 57-60. In M. A. Karmali, and A. G. Goglio (ed.), Recent advances in verocytotoxin-producing Escherichia coli infections. Elsevier Science B.V., Amsterdam, The Netherlands.
  74. Goldwater PN, Rice M. Primary meningococcal pneumonia in a nineteen month-old child. Pediatric Infectious Disease Journal 1995; 14: 155-156.
  75. Goldwater PN. Immunoglobulin M Capture Immunoassay in investigation of Coxsackie B5 and B6 Outbreaks in South Australia. J Clin Microbiol 1995; 33: 1628-1631.
  76. Goldwater PN, Bettelheim KA. The role of enterohaemorrhagic Escherichia coli serotypesother than O157:H7 as causes of disease in Australia. Communicable Disease Intelligence 1995: 19: 2-4.
  77. Cameron AS, Beers MY, Walker CC, Rose N, Anear E, Manatakis Z, Kirke K, Calder I, Jenkins F, Goldwater PN, Paton A, Paton J, Jureidini K, Hoffman A, Henning P, Hansman D, Lawrence A, Miller R, Ratcliff R, Doyle R, Murray C, Davos D, Cameron P, Seymour-Murray J, Lim I, Lanser J, Selvey L, Beaton S. Community outbreak of Hemolytic Uremic Syndrome attributable to Escherichia coli O111:H- - South Australia, 1995. MMWR; 1995; 44 (29): 550-553.
  78. Goldwater PN, Bettelheim KA. Outbreak of HUS in Adelaide associated with dry fermented sausage contaminated with VTEC O111:H-. Notiziario dell’Instituto Superiore di Sanita. 1995; 8 (4) (Suppl.2):1-2.
  79. Goldwater PN, Bettelheim KA. Haemolytic Uraemic Syndrome due to a Shiga-like toxin-producing Escherichia coli O48:H21 in South Australia. Emerging Infectious Diseases 1995; 1 (4): 132-133.
  80. Goldwater PN. Effect of Cefotaxime or Ceftriaxone treatment on nasopharyngeal Haemophilus influenzae  type b colonization in children. Antimicrobial Agents & Chemotherapy. 1995; 39: 2150-2152
  81. Goldwater PN, Bettelheim KA. An outbreak of hemolytic uremic syndrome due to Escherichia coli O157:H-.  Or was it? Emerging Infectious Diseases 1996; 2: 153-154.
  82. Goldwater, PN. Hepatitis B in Australia: on course for universal vaccination. (Editorial). Medical Journal of Australia 1996; 165: 300-301.
  83. Carmichael EM, Goldwater PN, Byard RW. Routine microbiological testing in sudden and unexpected infant death. J. Paed. Child Health 1996; 32; 412-415.
  84. Goldwater PN. Randomised, comparative trial of 20ug versus 40ug Engerix B vaccine in hepatitis B vaccine non-responders. Vaccine 1997; 14: 353-356.
  85. Goldwater PN. Post-exposure prophylaxis against blood-borne viruses. Current Therapeutics. 1998; 39: 61-66.
  86. Goldwater PN, Bettelheim KA. Review Article. New perspectives on the role of Escherichia coli O157:H7 and other enterohaemorrhagic E. coli serotypes in human disease. J Med Microbiol 1998;47: 1039-1045.
  87. Goldwater PN, Giles N, Bettelheim KA. An unusual case of microangiopathic haemolytic anaemia secondary to enterohaemorrhagic Escherichia coli O113:H21 infection, a shiga toxin-2 producing serotype. J Infection 1998; 37: 302-304.
  88. Bettelheim KA, Goldwater PN. Antibodies to O antigens of Escherichia coli in patients associated with an outbreak of foodborne haemolytic uraemic syndrome. In: Proceedings of the 4th World Congress of Foodborne Infections and  Intoxications, 7-12 June 1998, Berlin, Germany. Volume II. Federal Institute for Health Protection of Consumers and Veterinary Medicine. FAO/WHO Collaborating Centre for Research and Training in Food Hygiene and Zoonoses. pp 872 - 875.
  89. Goldwater PN. EHEC and human disease. Current Therapeutics 1998; 39:     25-29.
  90. Goldwater PN. Herpes whitlow: surgery is not indicated! Current Therapeutics 1999; 40 (10): 48-49.
  91. Kulkarni HA, Goldwater PN, Martin AA, Bettelheim KA. E. coli “O”group serology of an HUS epidemic. Acta Clinica Belgica 1999; 54 (1): 37.
  92. Goldwater PN, Bettelheim KA Escherichia coli 'O' group serology of a haemolytic  uraemic syndrome (HUS) epidemic. Scand J Infect Dis 2000; 32(4): 385-
  93. Goldwater PN. Herpes whitlow. New Ethicals Journal. 2000; 3: 65-66.
  94. Bettelheim KA, Goldwater PN.An Escherichia coli O157:H7 outbreak? Clin Infect Dis 2000; 30(6):  984.
  95. Honeyman MC, Coulson BS, Stone NL, Gellert SA, Goldwater PN, Steele E, Couper JJ, Tait BD, Colman PG, Harrison LC. Association between rotavirus   infection and pancreatic islet    autoimmunity in children at risk of developing type 1 diabetes. Diabetes 2000; 49: 1319-1324.
  96. Goldwater PN. Australian response to BSE. Aust Dental J 2000; 45: 290-1.
  97. Goldwater PN, Rowland K, Power R, Thesinger M, Abbott K, Grieve A, Palombo EA, Masendycz PJ, Wilkinson I, Bear J. Rotavirus encephalopathy: pathogenesis reviewed.  J Paed Child Health 2001; 37: 206-209.
  98. Goldwater PN. SIDS: more facts and controversies. Med J Aust 2001; 174; 302-304.
  99. Goldwater PN. Bovine Spongiform Encephalopathy and variant Creutzfeldt-Jakob disease: implications for Australia. Med J Aust 2001; 175: 154-158.
  100. Shanks D, Goldwater P, Pena A, Saxon B. Fatal Micrococcus sp. infection in child with leukaemia – a cautionary case. Medical and Pediatric Oncology 2001; 37: 553-4.
  101. Kulkarni HA, Goldwater PN, Martin AA, Bettelheim KA. Escherichia Coli “O” Group Serological Responses and Clinical Correlations in Epidemic HUS patients. Comp Immunol Microbiol Infect Dis 2002; 25: 249-268.
  102. Goldwater PN, Bettelheim KA. The Central Scotland Escherichia coli O157:H7 outbreak: Risk factors for the Hemolytic Uremic Syndrome and death among hospitalized patients. Clinical Infectious Diseases 2002; 35: 346-347.  
  103. Goldwater P, Bettelheim KA. Curliated Escherichia coli and the sudden infant death syndrome. Clinical Microbiology & Infection 2002; 8 (suppl 1): 23 (abstract O171).
  104. Goldwater PN. Viral Infections of the Skin: Management and Treatment. Current Therapeutics 2002; August: 65-69.
  105. Goldwater PN, Bettelheim KA. Verotoxigenic Escherichia coli serologic responses in patients with Hemolytic Uremic Syndrome. J Infect Dis 2002; 186: 582.
  106. Goldwater PN. Viral Infections of the Skin: Management and Treatment. New Ethicals Journal  2002; 5 (10): 61-65.
  107. Goldwater PN, Bettelheim KA. Curliated Escherichia coli, soluble curlin and the sudden infant death syndrome (SIDS). J Med Microbiol 2002; 51(11): 1009-1012.
  108. Gibson CS, Maclennan AH, Goldwater PN, Dekker GA. Antenatal Causes of Cerebral Palsy: Associations between inherited thrombophilias, viral and bacterial infection and inherited susceptibility to infection. Obstet Gynaecol Survey 2003; 58: 209-220.
  109. Goldwater PN. Sudden infant death syndrome: A critical review of approaches to research. Arch Dis Child  2003; 88:1095-1100.
  110. Goldwater PN, Braunack-Mayer AJ, Power RG, Henning PH, Gold MS, Donald TG, Jureidini JN, Finlay CF. Childhood tetanus in Australia: ethical issues for a should-be-forgotten preventable disease. Med J Aust 2003; 178: 175-177.
  111. Goldwater PN. Infection and Sudden Infant Death Syndrome (SIDS). Clinical Laboratory International 2003; 27(2): 6-10.
  112. Goldwater PN. Book Review. J Paediatr Child Health 2003; 39: 641-42.
  113.  Goldwater PN. SIDS pathogenesis: pathological findings indicate infection and inflammatory responses are involved. FEMS Immunol Med.Microbiol 2004: 42; 11-20.
  114. Bettelheim KA, Goldwater PN. Shiga Toxin-producing Escherichia coli (STEC) O111:H8 Outbreak. Clin Infect Dis; 2004; 39: 148.
  115. Gibson CS, MacLennan AH, Rudzki Z, Hague WM, Haan E, Sharpe P, Priest K, Chan A, Dekker GA, Goldwater PN et al. The Prevalence of Inherited Thrombophilias in a Caucasian Population. Pathology 2005;  37(2): 160–163.
  116. Gibson CS, MacLennan AH, Hague WM, Haan E, Priest K, Chan A, Dekker GA, Goldwater PN, et al. Associations between Inherited Thrombophilias, Gestational Age, and Cerebral Palsy. Am J Obstet Gynecol. 2005; 193(4): 1437e1-1437e12.
  117. Goldwater PN. Cefotaxime and ceftriaxone cerebrospinal fluid levels during treatment of bacterial meningitis in children. International Journal of Antimicrobial Chemotherapy.2005; 26 (5): 408-411.
  118. Gibson CS, MacLennan AH, Goldwater PN, Haan E, Priest K, Dekker GA. Neurotropic viruses and cerebral palsy: population based case-control study. Brit Med J. 2006; BMJ,doi:10.1136/bmj.38668.616806.3A (published 6 January 2006).
  119. Goldwater PN. A pilot study of SRL 172 (killed Mycobacterium vaccae) in healthy chronic hepatitis B carries and hepatitis B vaccine non-responders. Human Vaccines 2006; 2(1): e1-e6.
  120. Gibson CS, MacLennan AH, Goldwater PN, Haan EA, Priest K, Dekker GA for the South Australian Cerebral Palsy Research Group. The association between inherited cytokine polymorphisms and cerebral palsy. Am J Obstet Gynecol 2006; 194(3): 674e1-674e11
  121. Gibson CS, MacLennan AH, Janssen NG, Kist WJ, Hague WM, Haan EA, Goldwater PN, Priest K, Dekker GA.Associations between fetal inherited thrombophilia and adverse pregnancy outcomes. Am J Obstet Gynecol 2006;194:947 e1-10.
  122. Gibson CS, MacLennan AH, Dekker GA, Goldwater PN, Dambrosia JM, Munroe DJ, Tsang S, Stewart C, Nelson KB. Genetic polymorphisms and spontaneous preterm birth. Obstet Gynecol. 2007;109(2 Pt 1):384-91.
  123. Chan Y, Goldwater P, Saxon B. Successful treatment of cutaneous and subcutaneous zygomycosis in an immunocompromised patient with aplastic anaemia. J Paed Child Health 2007: 43(1-2):87-9.
  124. Goldwater PN. Treatment and prevention of Enterohemorrhagic Escherichia coli infection and haemolytic uremic syndrome. Expert Review of Anti-infective Therapy 2007; 5(4): 653-663.
  125. Chan Y, Smith D, Sadlon T, Scott JX, Goldwater PN. Herpes zoster due to Oka vaccine strain of varicella zoster virus in an immunosuppressed child post cord blood transplant. J Paediatr Child Health 2007; 43: 713-715.
  126. Gibson C, Goldwater P, MacLennan A, Haan E, Priest K, Dekker G. Fetal exposure to herpesviruses may be associated with pregnancy-induced hyperternsive disorders and preterm birth in a Caucasian population. BJOG 2008; 115: 492-500.
  127. Gibson CS, MacLennan AH, Goldwater PN, et al. Mannose-binding lectin haplotypes may be associated with cerebral palsy only after perinatal viral exposure. Am J Obstet Gynecol 2008;198:509.e1-509.e8.
  128. Goldwater PN. Sterile site infection at autopsy in sudden unexpected death in infancy. Arch Dis Child 2009; 94: 303-307. and 2008 Sep 15. [Epub ahead of print]
  129. Gibson CS, MacLennan AH, Dekker GA, Goldwater PN, Sullivan TR, Munroe DJ,  Tsang S, Stewart C, Nelson  B. Candidate Genes and Cerebral Palsy: A Population-Based Study. PEDIATRICS 2008; 122 (5): 1079-85.
  130. McMichael GL, Gibson CS, Goldwater PN, Haan EA, Priest K,  Dekker GA,MacLennan AH,  for the South Australian Cerebral Palsy Research Group.  Association of  Apolipoprotein E  genotype and cerebral palsy is not confirmed in a Caucasian  population.  Human Genetics 2008; 124(4):411-6. Epub 2008 Sep 23.
  131. Goldwater PN. Intrathoracic Petechial Haemorrhages in sudden infant death syndrome and other infant deaths: Time for re-examination? Pediatr Dev Pathol. 2008 Nov-Dec;11(6):450-5.
  132. Highet AR, Berry AM, Bettelheim KA, and Goldwater PN. The frequency of molecular detection of virulence genes encoding cytolysin A, high-pathogenicity island and cytolethal distending toxin of Escherichia coli in cases of sudden infant death syndrome does not differ from that in other infant deaths and healthy infants. J Med Microbiol 2009; 58: 285-289.
  133. Christopher C Blyth, Emma J Best,  Cheryl A Jones, Clare Nourse, Paul N Goldwater, Andrew J Daley, David Burgner, Guy Henry , Pamela Palasanthiran. Non-tuberculous Mycobacterial Infection in Children: A Prospective National Study.  Pediatr Infect Dis J. 2009 Jul 24. [Epub ahead of print] Volume 28, Number 9, 801–805.
  134. Highet, AR, Berry AM,  Goldwater PN. Novel hypothesis for unexplained Sudden Unexpected Death in Infancy (SUDI). Arch Dis Child 2009; 94(11):841-3. Epub 2009 May 3. doi:10.1136/adc.2009.158352 (in press).
  135. Gibson CS, MacLennan AH, Goldwater PN, Dekker GA, for the SOUTH Australian Cerebral Palsy Research Group. The antenatal causes of cerebral palsy – Genetic and viral associations.Fetal and Maternal Medicine Review 2008;19:3 181–20.
  136. Djukic M, Gibson CS, Maclennan AH, Goldwater PN, Haan EA, Mcmichael G, Priest K, Dekker GA, Hague WM, Chan A, Rudzki  Z, Van Essen P, Yee Khong  T, Morton  MR, Ranieri E, Scott  H, Tapp  H and Casey G. Genetic susceptibility to viral exposure may increase the risk of cerebral palsy. Australian and New Zealand Journal of Obstetrics and Gynaecology 2009; 49: 247–253.
  137. Pearce JL.,  Bettelheim KA, Luke RKJ, Goldwater PN. J Appl Microbiol Serotypes of Escherichia coli in Sudden Infant Death Syndrome. J Appl Microbiol 2010; 108: 731–735 and 2009 Jul 13. [Epub ahead of print]
  138.  Goldwater PN, Cooper C, Bhatia V. Maternal HIV Seroconversion at delivery without transmission. J Paediatr Child Health 2010 (in press) Published Online: Feb 16, 2010; 11:33PM
    DOI: 10.1111/j.1440-1754.2009.01693.x
  139. Highet, AR, Berry AM,  Goldwater PN. entitled “Distribution of Interleukin-1 receptor antagonist genotypes in Sudden Unexpected Death in Infancy (SUDI);unexplained SUDI have a higher frequency of allele 2.” Annals of Medicine 2010; 42(1): 64-9.
  140. McMichael GL, Gibson CS, O’Callaghan M, Goldwater PN, Dekker GA,Haan EA, MacLennan AH,  for the South Australian Cerebral Palsy Research Group.  DNA from Buccal swabs suitable for high-throughput SNP multiplex analysis.  Journal of Biomolecular Techniques 2009; 20(5): 232-5.
  141. Highet AR, Goldwater PN. Staphylococcal enterotoxin genes are common in Staphylococcus aureus intestinal flora in Sudden Infant Death Syndrome (SIDS) and live comparison infants. FEMS Immunol Med Microbiol. 2009; 57(2):151-5 and Aug 3. [Epub ahead of print]
  142. Highet AR,  Gibson CS,  Goldwater PN. Clostridium sordellii lethal toxin gene is not detectable by PCR in the intestinal flora of Sudden Infant Death Syndrome cases or infants who died of other causes. J Med Microbiol 2010; 59 (2): 251 – 253.
  143. Highet AR,  Gibson CS,  Goldwater PN. CD14 (C-260T) polymorphism is not associated with Sudden Infant Death Syndrome (SIDS) in a large South Australian cohort. Innate Immunity 2010 (accepted for publication).
  144. Highet AR,  Gibson CS,  Goldwater PN. A polymorphism in a staphylococcal enterotoxin receptor gene (T cell receptor BV3 recombination signal sequence) is not associated with unexplained sudden unexpected death in infancy in an Australian cohort. Microbial Pathogenesis 2010 Mar 31. [Epub ahead of print].
  145. O’Callaghan ME, MacLennan AH, GibsonCS, McMichael GL, Haan EA, Broadbent J, Priest K, Goldwater PN, Dekker G for the Australian Collaborative Cerebral Palsy Research Group. The Australian Cerebral Palsy Research Study Protocol for a national collaborative study investigating genomic and clinical associations with cerebral palsy. J Paediatr Child Health 2010 (accepted )
  146. Burgner D, Davila S, Breunis WB, Ng SB, Li Y, Bonnard C, Ling L, Wright VJ, Thalamuthu A, Odam M, Shimizu C, Burns JC., Levin M, Kuijpers TW, Hibberd ML, International Kawasaki Disease Genetics Consortium. A Genome-Wide Association Study Identifies Novel and Functionally Related Susceptibility Loci for Kawasaki Disease. PLoS Genetics  2009; 5 (1): e1000319.
  147. Highet AR,  Gibson CS,  Goldwater PN. Variant Interleukin 1 receptor antagonist gene alleles in Sudden Infant Death Syndrome (SIDS). Arch Dis Child 2010 (accepted for publication)
  148. McMichael GL,, Highet AR,  Gibson CS,  Goldwater PN, O’Callaghan ME, Alvino E,  MacLennan AH,, for the South Australian Cerebral Palsy Research Group.Comparison of DNA extraction methods from small samples of newborn screening cards suitable for retrospective perinatal viral research. Journal of Biomolecular Techniques (accepted for publication)

Book:

Goldwater, Paul N.  “AIDS : The risk.”  Penguin Books Ltd. l986.

  1. Goldwater, PN, Foster,  JS. l976  Chronic  Chest Wall Sinus : An unusual presentation of typhoid. NZ Med J. 83: 116-117.
  2. Goldwater, PN, Laws, J.  1977.  Echovirus 19 outbreak in Auckland, 1975- 76. NZ Med J. 86: 319-322.
  3. Goldwater, PN, Quiney, JR,  Banatvala, JE. l978.  Maternal Rubella at St. Thomas’ Hospital.   Is there a need to change British vaccination policy?  Lancet 2:  1298-1300.
  4. Goldwater, PN. l979.  Gastroenteritis in Auckland: an aetiological and clinical study.  J. Infection. l: 339-35l.
  5. Goldwater, PN, Chrystie, IL, Banatvala, JE. l979.  Rotaviruses and the Respiratory Tract.  Brit. Med. J. 2: l55l.
  6. Goldwater, PN, Chrystie,  IL.  l979.  Retrieving  Specimen Holders. Proc. Roy. Microscopical Soc. 14: 374-376.
  7. Goldwater,  PN,  Banatvala,  JE.  l98l.   Solid-phase immunosorbent haemadsorption   (SPIHAD):  A  new,  rapid   and  simple  test  for rubella-specific IgM. J. Virol. Method. 2: 34l-347.
  8. Goldwater, PN, Webster,  M, Banatvala, JE.  l982.  Use of  a simple new test for virus-specific  IgM  to  investigate  an  outbreak  of influenza B  in a  hospitalised aged  community. J.Virol.Method 4: 9-l8.
  9. Goldwater, PN, Bettelheim, KA, Ellis-Pegler, RB. l98l.  Escherichia coli in  gastroenteritis of children in  Auckland, New Zealand.  J. Hyg. Camb. 87: 413-419.
  10. 0.     Goldwater, PN, Woodfield, DG, Anderson, RA, Gill, MB, Carpenter, S. l982.   Acute sporadic Non-A, non-B hepatitis in an urban community in New Zealand, Aust. N.Z.  J. Med. 12: 268-27l.
  11. 1.     Goldwater, PN, Woodfield, DG, Anderson, RA, Gill, MB, Carpenter, S. l982.   Acute sporadic Non-A, non-B hepatitis in Auckland. In Viral Diseases of South-East  Asia and the  Western Pacific, pp  40l-402. Ed J.S. Mackenzie, Academic Press, l982.
  12. 2.     Goldwater,  PN,  l982.  Markers  of  double infections (abstract in Hepatitis   B  in  New  Zealand,  Report  of  a  workshop  held  at Whakatane).   Published  by  the  Pathology  Laboratory, Whakatane Public Hospital.
  13. 3.     Goldwater, PN. l983.  The control of  hepatitis B in  the hospital setting.   The Dissector (The Journal of Theatre Nurses’ Section of NZNA) 10: 10-13.
  14. 4.     Goldwater, PN. l983.  Infectious mononucleosis: Current  Concepts, Recognition and Management.  September, 89-99.
  15. 5.     Goldwater, PN.  l984.  Acyclovir  (Guest Editorial),  New Ethicals. February, 9-11.
  16. 6.     Goldwater,  PN,  Ikin,  P.  Baguley,  BC.  l983.    Antiherpesvirus activity of AMSA  derivatives.   Proc.  Auckland  Medical  Research Club, NZ Med J. 96: 302
  17. 7.     Goldwater, PN,  Flynn, K.  Baguley, BC.  l984.  Anilinoacridines: A new class  of compound active against  Herpes Simplex virus.  Proc. Auckland Medical Research Club, NZ Med J. 97: 193.
  18. 8.     Goldwater,  PN,  Gunn,  C,  Flynn,  KE,  Baguley,  BC.  l985.  Can 9-anilinoacridines eliminate latent  herpes?   Herpes  Viruses  and Virus  Chemotherapy.  Pharmacological  and  Clinical Approaches. R. Kono, A. Nakajima, Eds.  Excerpta  Medica.  International  Congress Series 667, P.243-246.
  19. 9.     Goldwater, PN, l984.  Antiviral Drugs Today.  Editorial NZ Med.  J. 97: 852-854.
  20. 0.     Goldwater, PN.  l984.  Hepatitis  B vaccine.  Cost-effective use in the hospital setting.  Guest editorial Hospital Therapeutics l (l): 5-9.
  21. 1.     Goldwater, PN.  l985.  Viral  Hepatitis  Identified II: Active or Passive Immunization?  Patient Management, l4: 37-48.
  22. 2.     Goldwater, PN.  l985.   Hepatitis B Review. New  ZealandMicrobiological Society Newsletter, February, 12-15.
  23. 3.     Goldwater,   PN,   Flynn,   KE,   Gunn,   CI,  Baguley,  BC.  9-anilinoacridines:  Novel compounds active  against herpes simplex virus.  Chemico-Biological Interactions. 66; 377-382.
  24. 4.     Goldwater,  PN,  Synek,  BJL,   Koelmeyer  TD,  Scott,  PJ.   l985. Structures resembling  scrapie-associated  fibrils  found  in  AIDS encephalopathy.   Lancet ii; 447-448.
  25. 5.     Goldwater, PN, Abbott, M.  (Editors).  Preventive Medicine and the Nuclear Arms Race.  Mental Health Foundation of New Zealand, l985.
  26. 6.     Gunn, CS, Goldwater, PN. l986.  An in vitro reactivation system for investigation of Herpes Simplex virus latency.  J. Med. Virol. l8; 247-254.
  27. 7.     Buchanan,  JG,  Goldwater,  PN,  Somerfield,  SD,  Tobias, M. l986. Acute  HTLV-III-associated mononucleosis  syndrome. NZ  Med J  99 : 405-408.
  28. 8.     Goldwater,  PN.  l986.    DNA  Hybridization  in   Diagnosis. New Frontiers in Medicine.,Patient Management.l5 (l):74-78.
  29. 9.     Goldwater,  PN,  Woodfield,  DG,  Ramirez,  AM,  Steed,  I.   l986. Intradermal, Low Dose,  Short Course  Hepatitis B  Vaccination.  NZ Med J 99: 703-705.
  30. 0.     Nixon, AD, Law, R, Officer,  JA, Cleland, JF, Goldwater, PN.  l986. Simple  device to prevent accidental needle-prick injuries.  Lancet i: 888-889.
  31. 1.     Moyes, CD, Milne,  A, Dimitrakakis, M,  Goldwater, PN.  l987.  Very low dose  hepatitis B vaccine  in Neonates: an  economic option for hepatitis B control in endemic areas.  Lancet i : 29-31.
  32. 2.     Milne,  A,  Allwood,  G,  Campbell,  C,  Dimitrikakas, M, Lucas, R, Goldwater, PN,  Pearce N,  Krugman, S.  1987.  Low dose vaccination against  hepatitis  B:  one  year  follow  up.  J Med Virol. 22 : 387-392.
  33. 3.     Goldwater PN. l986.  Out of Africa. NZ Med J. 99 : 770.
  34. 4.     Goldwater PN. l986.  Scrapie-associated fibrils and AIDS encephalopathy.  Biomedicine & Pharmacotherapy.  40 : 424
  35. 5.     Lane MR, Hannon S, Woodfield DG, Goldwater PN, Lee SP. l987. Acute viral Hepatitis in Auckland. NZ Med J. l00: 99-102.
  36. 6.     Goldwater PN l987. Hepatitis  B Vaccination : Present  and Future. Hospital Therapeutics 28 (5) : 25-34.
  37. 7.     Goldwater PN  1987.  Hepatitis  B Vaccination : Present  and Future. Medical Progress l4 : 11-17.
  38. 8.     Goldwater PN.  1987.  Device to permit recapping of syringes without risk of infection.  Brit. Med. J. 295: 668.
  39. 9.     Goldwater PN.  1987.  AIDS - The need for appropriate  action.  The Needle l: 15-16.
  40. 0.     Goldwater PN,  Kernick  CG,  Martin  AJ, Delbridge RG, Matthews NT 1988.   False negative HIV serology in a case of congenital/perinatal AIDS.  Aust. Paediatr. J. 24 : 199-202.
  41. 1.     Goldwater, PN. 1988. Hepatitis B Vaccination.  The Physician India. 4(1) : 50-54.
  42. 2.     Goldwater PN, Paton JC.  1988.  Apparent non-involvement of  prions in  the pathogenesis  of spongiform  change in  HIV-infected brain. Journal of  Neuropathology and  Experimental Neurology.  1989; 48 : 184-186.
  43. 3.     Goldwater PN, Law R, Nixon AD, Officer JA, Cleland JF.  Impact of a recappping  device on  venepucture-related  needlestick  injury. Infect Control Hosp Epidemiol 1989; 10 : 21-25.
  44. 4.     Goldwater PN.  Occupational HIV risk. NZ  Med J 1989; 102: 231. (letter).
  45. 5.     Goldwater PN.  Exposure of health care workers to the blood of patients infected with the human immunodeficiency virus. New Engl J Med 1989; 320: 1350-1351.
  46. 6.     Goldwater PN.  A fresh look at the transmission of the human immunodeficiency virus.  Med J Australia 1989, 151 : 359-360.
  47. 7.     Bettleheim  KA,  Dwyer  BW,  Smith  DL,  Goldwater  PN,  Bourne AJ. Toxigenic Escherichia coli associated  with  sudden  infant  death syndrome.  Med J Australia, 1989; 151 : 538.
  48. 8.     Bettelheim  KA,  Goldwater  PN,  Dwyer  BW,  Bourne  AJ,  Smith DL. Toxigenic Escherichia coli associated  with  sudden  infant  death syndrome. Scand J Infect Dis 1990; 22: 467-476.
  49. 9.     Goldwater PN.  Aetiopathological correlation in the  sudden infant death syndrome. NZ Med J 1990; 102: 226.
  50. 0.     Goldwater PN, Williams V, Bourne AJ, Byard RW.  Sudden infant death syndrome : a possible clue to causation.  Med J Australia 1990; 153 : 59-60.
  51. 1.     Paton AW, Goldwater PN.  Respiratory Syncytial Virus modulation of adult and  neonatal lymphocyte mitogenic responses  and the role of interferon gamma. Microbial Pathogenesis 1990; 9: 235-241.
  52. 2.     Goldwater PN, Martin AJ, Ryan B, Morris S, Thompson J, Kok TW, Burrell CJ. A survey of nosocomial respiratory viral infections in a children’s hospital: Occult respiratory infection in patients admitted during an epidemic season. Infection Control and Hospital Epidemiology 1991; 12: 231-238.
  53. 3.     Goldwater PN. Preventing needlestick injuries. Brit Med J 1991; 302: 1602-1603 (letter).
  54. 4.     Bettelheim KA, Smith H, Goldwater PN, Morris JA, Murrell TGC, Sweet C, Weaver S. Sleeping position and cot deaths. Lancet 1991; 338: 192 (letter).
  55. 5.     Goldwater PN. Which antibiotic and when. Australian Family Physician. 1991; 20: 579-585.
  56. 6.     Bettelheim KA, Goldwater PN, Evangelidis H, Pearce JL, Smith DL. Distribution of toxigenic Escherichia coli serotypes in the intestines of infants. Comp Immun Microbiol Infect Dis 1992; 15: 65-70.
  57. 7.     Goldwater PN. Reappraisal of the SIDS enigma: An epidemiological and clinicopathogical approach. J Paediatr Child Health 1992; Suppl. 1, S21-25.
  58. 8.     Paton AW, Paton JC, Lawrence AJ, Goldwater PN, Harris RJ. Rapid detection of respiratory syncytial virus in nasopharyngeal apirates by reverse transcription and polymerase chain reaction amplification. J Clin Microbiol 1992; 30: 901-904.
  59. 9.     Byard RW, Moore L, Bourne AJ, Lawrence AJ, Goldwater PN. Clostridium botulinum and sudden infant death syndrome: A 10 year prospective study. J. Paediatr Child Health 1992; 28: 156-157.
  60. 0.     Goldwater P. Coxsackie B5 Cluster in Adelaide, September-October 1992. Communicable Disease Intelligence 1992; 16: 500.
  61. 1.     Bettelheim KA, Evangelidis H, Pearce JL, Goldwater PN, Luke RK. The isolation of cytotoxic necrotising factor (CNF)-producing Escherichia coli from the intestinal contents of babies who died of sudden infant death syndrome and other causes as well as from the faeces of healthy babies. Comp Immunol Microbiol Infect Dis 1992; 16: 87-90. 
  62. 2.     Smith PK, Goldwater PN. Kawasaki Disease in Adelaide: A Review. J Paediatr Child Health 1993; 29: 126-131.
  63. 3.     Byard RW, Bourne AJ, Matthews N, Roberton DM, Goldwater PN, Hansman D. Pulmonary strongyloidiasis in a child diagnosed on open lung biopsy. Surgical Pathology 1993; 5: 55-62.
  64. 4.     Paton AW, Paton JC, Goldwater PN, Heuzenroeder MW, Manning PA. Sequence of a variant Shiga-like toxin type-I operon of Escherichia coli O111:H- Gene 1993; 129: 87-92.
  65. 5.     Paton AW, Paton JC, Goldwater PN, Heuzenroeder MW, Manning PA. Cloning and nucleotide sequence of a variant Shiga-like toxin II gene from Escherichia coli OX3:H21 isolated from a case of sudden infant death syndrome. Microbial Pathogenesis 1992; 13: 225-236.
  66. 6.     Goldwater PN. Update: The immunization schedule. The Women’s and Children’s Hospital Clinical Quarterly. 1993; 6: 1-2. 
  67. 7.     Goldwater PN. History of hepatitis B vaccination in New Zealand: Lessons for Australia? Aust J Public Health 1993; 17: 221-225.
  68. 8.     Paton AW, Paton JC, Goldwater PN, Manning PA. Direct detection of Escherichia coli shiga-like toxin genes in primary fecal cultures using polymerase chain reaction. J Clin Microbiol 1993; 31: 3063-3067.           
  69. 9.     Goldwater PN. Randomised comparative trial of interferon-a versus placebo in hepatitis B vaccine non- and hypo-responders. Vaccine 1994; 12: 410-414.
  70. 0.     Bettelheim KA, Pearce JL, Evangelidis H, Goldwater PN. A mouse model for sudden infant death syndrome. Proc. Second SIDS Family International Conference, Sydney 1992. Perinatology Press, eds Walker AM, McMillen C. Ithica, NY, 1993. pp 121-123.
  71. 1.     Davis SR, Ellis DH, Goldwater PN, Dimitriou S, Byard R. First human culture-proven Australian case of entomophthoromycosis caused by Basidiobolus ranarum. J Med Vet Mycol 1994; 32: 225-230.
  72. 2.     Maxwell FC, Couper RTL, Morris LL, Goldwater PN, Hansman DJ. Meningitis and sphenoidal sinusitis associated with free gas in the suprasellar cistern. Pediatric Radiology 1994; 24:594-595.
  73. 3.     Goldwater PN and Bettelheim KA. 1994. The role of enterohaemorrhagic E. coli serotypes other than O157:H7 as causes of disease, p. 57-60. In M. A. Karmali, and A. G. Goglio (ed.), Recent advances in verocytotoxin-producing Escherichia coli infections. Elsevier Science B.V., Amsterdam, The Netherlands.
  74. 4.     Goldwater PN, Rice M. Primary meningococcal pneumonia in a nineteen month-old child. Pediatric Infectious Disease Journal 1995; 14: 155-156.
  75. 5.     Goldwater PN. Immunoglobulin M Capture Immunoassay in investigation of Coxsackie B5 and B6 Outbreaks in South Australia. J Clin Microbiol 1995; 33: 1628-1631.
  76. 6.     Goldwater PN, Bettelheim KA. The role of enterohaemorrhagic Escherichia coli serotypesother than O157:H7 as causes of disease in Australia. Communicable Disease Intelligence 1995: 19: 2-4.
  77. 7.     Cameron AS, Beers MY, Walker CC, Rose N, Anear E, Manatakis Z, Kirke K, Calder I, Jenkins F, Goldwater PN, Paton A, Paton J, Jureidini K, Hoffman A, Henning P, Hansman D, Lawrence A, Miller R, Ratcliff R, Doyle R, Murray C, Davos D, Cameron P, Seymour-Murray J, Lim I, Lanser J, Selvey L, Beaton S. Community outbreak of Hemolytic Uremic Syndrome attributable to Escherichia coli O111:H- - South Australia, 1995. MMWR; 1995; 44 (29): 550-553.
  78. 8.     Goldwater PN, Bettelheim KA. Outbreak of HUS in Adelaide associated with dry fermented sausage contaminated with VTEC O111:H-. Notiziario dell’Instituto Superiore di Sanita. 1995; 8 (4) (Suppl.2):1-2.
  79. 9.     Goldwater PN, Bettelheim KA. Haemolytic Uraemic Syndrome due to a Shiga-like toxin-producing Escherichia coli O48:H21 in South Australia. Emerging Infectious Diseases 1995; 1 (4): 132-133.
  80. 0.     Goldwater PN. Effect of Cefotaxime or Ceftriaxone treatment on nasopharyngeal Haemophilus influenzae  type b colonization in children. Antimicrobial Agents & Chemotherapy. 1995; 39: 2150-2152
  81. 1.     Goldwater PN, Bettelheim KA. An outbreak of hemolytic uremic syndrome due to Escherichia coli O157:H-.  Or was it? Emerging Infectious Diseases 1996; 2: 153-154.
  82. 2.     Goldwater, PN. Hepatitis B in Australia: on course for universal vaccination. (Editorial). Medical Journal of Australia 1996; 165: 300-301.
  83. 3.     Carmichael EM, Goldwater PN, Byard RW. Routine microbiological testing in sudden and unexpected infant death. J. Paed. Child Health 1996; 32; 412-415.
  84. 4.     Goldwater PN. Randomised, comparative trial of 20ug versus 40ug Engerix B vaccine in hepatitis B vaccine non-responders. Vaccine 1997; 14: 353-356.
  85. 5.     Goldwater PN. Post-exposure prophylaxis against blood-borne viruses. Current Therapeutics. 1998; 39: 61-66.
  86. 6.     Goldwater PN, Bettelheim KA. Review Article. New perspectives on the role of Escherichia coli O157:H7 and other enterohaemorrhagic E. coli serotypes in human disease. J Med Microbiol 1998;47: 1039-1045.
  87. 7.     Goldwater PN, Giles N, Bettelheim KA. An unusual case of microangiopathic haemolytic anaemia secondary to enterohaemorrhagic Escherichia coli O113:H21 infection, a shiga toxin-2 producing serotype. J Infection 1998; 37: 302-304.
  88. 8.     Bettelheim KA, Goldwater PN. Antibodies to O antigens of Escherichia coli in patients associated with an outbreak of foodborne haemolytic uraemic syndrome. In: Proceedings of the 4th World Congress of Foodborne Infections and  Intoxications, 7-12 June 1998, Berlin, Germany. Volume II. Federal Institute for Health Protection of Consumers and Veterinary Medicine. FAO/WHO Collaborating Centre for Research and Training in Food Hygiene and Zoonoses. pp 872 - 875.
  89. 9.     Goldwater PN. EHEC and human disease. Current Therapeutics 1998; 39:     25-29.
  90. 0.     Goldwater PN. Herpes whitlow: surgery is not indicated! Current Therapeutics 1999; 40 (10): 48-49.
  91. 1.     Kulkarni HA, Goldwater PN, Martin AA, Bettelheim KA. E. coli “O”group serology of an HUS epidemic. Acta Clinica Belgica 1999; 54 (1): 37.
  92. 2.     Goldwater PN, Bettelheim KA Escherichia coli 'O' group serology of a haemolytic  uraemic syndrome (HUS) epidemic. Scand J Infect Dis 2000; 32(4): 385-
  93. 3.     Goldwater PN. Herpes whitlow. New Ethicals Journal. 2000; 3: 65-66.
  94. 4.     Bettelheim KA, Goldwater PN.An Escherichia coli O157:H7 outbreak? Clin Infect Dis 2000; 30(6):  984.
  95. 5.     Honeyman MC, Coulson BS, Stone NL, Gellert SA, Goldwater PN, Steele E, Couper JJ, Tait BD, Colman PG, Harrison LC. Association between rotavirus   infection and pancreatic islet    autoimmunity in children at risk of developing type 1 diabetes. Diabetes 2000; 49: 1319-1324.
  96. 6.     Goldwater PN. Australian response to BSE. Aust Dental J 2000; 45: 290-1.
  97. 7.     Goldwater PN, Rowland K, Power R, Thesinger M, Abbott K, Grieve A, Palombo EA, Masendycz PJ, Wilkinson I, Bear J. Rotavirus encephalopathy: pathogenesis reviewed.  J Paed Child Health 2001; 37: 206-209.
  98. 8.     Goldwater PN. SIDS: more facts and controversies. Med J Aust 2001; 174; 302-304.
  99. 9.     Goldwater PN. Bovine Spongiform Encephalopathy and variant Creutzfeldt-Jakob disease: implications for Australia. Med J Aust 2001; 175: 154-158.
  100. 00.  Shanks D, Goldwater P, Pena A, Saxon B. Fatal Micrococcus sp. infection in child with leukaemia – a cautionary case. Medical and Pediatric Oncology 2001; 37: 553-4.
  101. 01.  Kulkarni HA, Goldwater PN, Martin AA, Bettelheim KA. Escherichia Coli “O” Group Serological Responses and Clinical Correlations in Epidemic HUS patients. Comp Immunol Microbiol Infect Dis 2002; 25: 249-268.
  102. 02.  Goldwater PN, Bettelheim KA. The Central Scotland Escherichia coli O157:H7 outbreak: Risk factors for the Hemolytic Uremic Syndrome and death among hospitalized patients. Clinical Infectious Diseases 2002; 35: 346-347.  
  103. 03.  Goldwater P, Bettelheim KA. Curliated Escherichia coli and the sudden infant death syndrome. Clinical Microbiology & Infection 2002; 8 (suppl 1): 23 (abstract O171).
  104. 04.  Goldwater PN. Viral Infections of the Skin: Management and Treatment. Current Therapeutics 2002; August: 65-69.
  105. 05.  Goldwater PN, Bettelheim KA. Verotoxigenic Escherichia coli serologic responses in patients with Hemolytic Uremic Syndrome. J Infect Dis 2002; 186: 582.
  106. 06.  Goldwater PN. Viral Infections of the Skin: Management and Treatment. New Ethicals Journal  2002; 5 (10): 61-65.
  107. 07.  Goldwater PN, Bettelheim KA. Curliated Escherichia coli, soluble curlin and the sudden infant death syndrome (SIDS). J Med Microbiol 2002; 51(11): 1009-1012.
  108. 08.  Gibson CS, Maclennan AH, Goldwater PN, Dekker GA. Antenatal Causes of Cerebral Palsy: Associations between inherited thrombophilias, viral and bacterial infection and inherited susceptibility to infection. Obstet Gynaecol Survey 2003; 58: 209-220.
  109. 09.  Goldwater PN. Sudden infant death syndrome: A critical review of approaches to research. Arch Dis Child  2003; 88:1095-1100.
  110. 10.  Goldwater PN, Braunack-Mayer AJ, Power RG, Henning PH, Gold MS, Donald TG, Jureidini JN, Finlay CF. Childhood tetanus in Australia: ethical issues for a should-be-forgotten preventable disease. Med J Aust 2003; 178: 175-177.
  111. 11.  Goldwater PN. Infection and Sudden Infant Death Syndrome (SIDS). Clinical Laboratory International 2003; 27(2): 6-10.
  112. 12.  Goldwater PN. Book Review. J Paediatr Child Health 2003; 39: 641-42.
  113. 13.  Goldwater PN. SIDS pathogenesis: pathological findings indicate infection and inflammatory responses are involved. FEMS Immunol Med.Microbiol 2004: 42; 11-20.
  114. 14.  Bettelheim KA, Goldwater PN. Shiga Toxin-producing Escherichia coli (STEC) O111:H8 Outbreak. Clin Infect Dis; 2004; 39: 148.
  115. 15.  Gibson CS, MacLennan AH, Rudzki Z, Hague WM, Haan E, Sharpe P, Priest K, Chan A, Dekker GA, Goldwater PN et al. The Prevalence of Inherited Thrombophilias in a Caucasian Population. Pathology 2005;  37(2): 160–163.
  116. 16.  Gibson CS, MacLennan AH, Hague WM, Haan E, Priest K, Chan A, Dekker GA, Goldwater PN, et al. Associations between Inherited Thrombophilias, Gestational Age, and Cerebral Palsy. Am J Obstet Gynecol. 2005; 193(4): 1437e1-1437e12.
  117. 17.  Goldwater PN. Cefotaxime and ceftriaxone cerebrospinal fluid levels during treatment of bacterial meningitis in children. International Journal of Antimicrobial Chemotherapy.2005; 26 (5): 408-411.
  118. 18.  Gibson CS, MacLennan AH, Goldwater PN, Haan E, Priest K, Dekker GA. Neurotropic viruses and cerebral palsy: population based case-control study. Brit Med J. 2006; BMJ,doi:10.1136/bmj.38668.616806.3A (published 6 January 2006).
  119. 19.  Goldwater PN. A pilot study of SRL 172 (killed Mycobacterium vaccae) in healthy chronic hepatitis B carries and hepatitis B vaccine non-responders. Human Vaccines 2006; 2(1): e1-e6.
  120. 20.  Gibson CS, MacLennan AH, Goldwater PN, Haan EA, Priest K, Dekker GA for the South Australian Cerebral Palsy Research Group. The association between inherited cytokine polymorphisms and cerebral palsy. Am J Obstet Gynecol 2006; 194(3): 674e1-674e11
  121. 21.  Gibson CS, MacLennan AH, Janssen NG, Kist WJ, Hague WM, Haan EA, Goldwater PN, Priest K, Dekker GA.Associations between fetal inherited thrombophilia and adverse pregnancy outcomes. Am J Obstet Gynecol 2006;194:947 e1-10.
  122. 22.  Gibson CS, MacLennan AH, Dekker GA, Goldwater PN, Dambrosia JM, Munroe DJ, Tsang S, Stewart C, Nelson KB. Genetic polymorphisms and spontaneous preterm birth. Obstet Gynecol. 2007;109(2 Pt 1):384-91.
  123. 23.  Chan Y, Goldwater P, Saxon B. Successful treatment of cutaneous and subcutaneous zygomycosis in an immunocompromised patient with aplastic anaemia. J Paed Child Health 2007: 43(1-2):87-9.
  124. 24.  Goldwater PN. Treatment and prevention of Enterohemorrhagic Escherichia coli infection and haemolytic uremic syndrome. Expert Review of Anti-infective Therapy 2007; 5(4): 653-663.
  125. 25.  Chan Y, Smith D, Sadlon T, Scott JX, Goldwater PN. Herpes zoster due to Oka vaccine strain of varicella zoster virus in an immunosuppressed child post cord blood transplant. J Paediatr Child Health 2007; 43: 713-715.
  126. 26.  Gibson C, Goldwater P, MacLennan A, Haan E, Priest K, Dekker G. Fetal exposure to herpesviruses may be associated with pregnancy-induced hyperternsive disorders and preterm birth in a Caucasian population. BJOG 2008; 115: 492-500.
  127. 27.  Gibson CS, MacLennan AH, Goldwater PN, et al. Mannose-binding lectin haplotypes may be associated with cerebral palsy only after perinatal viral exposure. Am J Obstet Gynecol 2008;198:509.e1-509.e8.
  128. 28.  Goldwater PN. Sterile site infection at autopsy in sudden unexpected death in infancy. Arch Dis Child 2009; 94: 303-307. and 2008 Sep 15. [Epub ahead of print]
  129. 29.  Gibson CS, MacLennan AH, Dekker GA, Goldwater PN, Sullivan TR, Munroe DJ,  Tsang S, Stewart C, Nelson  B. Candidate Genes and Cerebral Palsy: A Population-Based Study. PEDIATRICS 2008; 122 (5): 1079-85.
  130. 30.  McMichael GL, Gibson CS, Goldwater PN, Haan EA, Priest K,  Dekker GA,MacLennan AH,  for the South Australian Cerebral Palsy Research Group.  Association of  Apolipoprotein E  genotype and cerebral palsy is not confirmed in a Caucasian  population.  Human Genetics 2008; 124(4):411-6. Epub 2008 Sep 23.
  131. 31.  Goldwater PN. Intrathoracic Petechial Haemorrhages in sudden infant death syndrome and other infant deaths: Time for re-examination? Pediatr Dev Pathol. 2008 Nov-Dec;11(6):450-5.
  132. 32.  Highet, AR, Berry AM,  Goldwater PN. Novel hypothesis for unexplained Sudden Unexpected Death in Infancy (SUDI). Arch Dis Child 2009; 94(11):841-3. Epub 2009 May 3. doi:10.1136/adc.2009.158352 (in press).
  133. 33.  Gibson CS, MacLennan AH, Goldwater PN, Dekker GA, for the SOUTH Australian Cerebral Palsy Research Group. The antenatal causes of cerebral palsy – Genetic and viral associations.Fetal and Maternal Medicine Review 2008;19:3 181–20.
  134. 34.  Djukic M, Gibson CS, Maclennan AH, Goldwater PN, Haan EA, Mcmichael G, Priest K, Dekker GA, Hague WM, Chan A, Rudzki  Z, Van Essen P, Yee Khong  T, Morton  MR, Ranieri E, Scott  H, Tapp  H and Casey G. Genetic susceptibility to viral exposure may increase the risk of cerebral palsy. Australian and New Zealand Journal of Obstetrics and Gynaecology 2009; 49: 247–253.
  135. 35.  Pearce JL.,  Bettelheim KA, Luke RKJ, Goldwater PN. J Appl Microbiol Serotypes of Escherichia coli in Sudden Infant Death Syndrome. J Appl Microbiol 2010; 108: 731–735 and 2009 Jul 13. [Epub ahead of print]
  136. 36.  GoldwaterPN, Cooper C, Bhatia V. Maternal HIV Seroconversion at delivery without transmission. J Paediatr Child Health 2010(in press) Published Online: Feb 16, 2010; 11:33PM
    DOI: 10.1111/j.1440-1754.2009.01693.x
  137. 37.  Highet, AR, Berry AM,  Goldwater PN. “Distribution of Interleukin-1 receptor antagonist genotypes in Sudden Unexpected Death in Infancy (SUDI);unexplained SUDI have a higher frequency of allele 2.” Annals of Medicine 2010; 42(1): 64-9.
  138. 38.  McMichael GL, Gibson CS, O’Callaghan M, Goldwater PN, Dekker GA,Haan EA, MacLennan AH,  for the South Australian Cerebral Palsy Research Group.  DNA from Buccal swabs suitable for high-throughput SNP multiplex analysis.  Journal of Biomolecular Techniques 2009; 20(5): 232-5.
  139. 39.  Highet AR, Goldwater PN. Staphylococcal enterotoxin genes are common in Staphylococcus aureus intestinal flora in Sudden Infant Death Syndrome (SIDS) and live comparison infants. FEMS Immunol Med Microbiol. 2009; 57(2):151-5 and Aug 3. [Epub ahead of print]
  140. 40.  Highet AR,  Gibson CS,  Goldwater PN. Clostridium sordellii lethal toxin gene is not detectable by PCR in the intestinal flora of Sudden Infant Death Syndrome cases or infants who died of other causes. J Med Microbiol 2010; 59 (2): 251 – 253.
  141. 41.  Highet AR,  Gibson CS,  Goldwater PN. CD14 (C-260T) polymorphism is not associated with Sudden Infant Death Syndrome (SIDS) in a large South Australian cohort. Innate Immunity 2010; 17(3): 321-326. Epub 2010 May 14.
  142. 42.  Highet AR,  Gibson CS,  Goldwater PN. A polymorphism in a staphylococcal enterotoxin receptor gene (T cell receptor BV3 recombination signal sequence) is not associated with unexplained sudden unexpected death in infancy in an Australian cohort. Microbial Pathogenesis 2010 Mar 31. [Epub ahead of print].
  143. 43.  O’Callaghan ME, MacLennan AH, Gibson CS, McMichael GL, Haan EA, Broadbent J, Priest K, Goldwater PN, Dekker G for the Australian Collaborative Cerebral Palsy Research Group. The Australian Cerebral Palsy Research Study Protocol for a national collaborative study investigating genomic and clinical associations with cerebral palsy. J Paediatr Child Health 2011; 47(3): 99-110. doi: 10.1111/j.1440-1754.2010.01896.x. Epub 2010 Nov 21.
  144. 44.  Burgner D, Davila S, Breunis WB, Ng SB, Li Y, Bonnard C, Ling L, Wright VJ, Thalamuthu A, Odam M, Shimizu C, Burns JC., Levin M, Kuijpers TW, Hibberd ML, International Kawasaki Disease Genetics Consortium (includes Goldwater PN as co-author). A Genome-Wide Association Study Identifies Novel and Functionally Related Susceptibility Loci for Kawasaki Disease. PLoS Genetics  2009; 5 (1): e1000319.
  145. 45.  Highet AR,  Gibson CS,  Goldwater PN. Variant Interleukin 1 receptor antagonist gene alleles in Sudden Infant Death Syndrome (SIDS). Arch Dis Child 2010;  95(12):1009-12.
  146. 46.  McMichael GL,, Highet AR,  Gibson CS,  Goldwater PN, O’Callaghan ME, Alvino E,  MacLennan AH,, for the South Australian Cerebral Palsy Research Group.Comparison of DNA extraction methods from small samples of newborn screening cards suitable for retrospective perinatal viral research. Journal of Biomolecular Techniques. 2011; 22(1): 5-9.
  147. 47.  Khor CC, Davila S, Shimizu C, Sheng S, Matsubara T, Suzuki Y, Newburger JW, Baker A, Burgner D, Breunis W, Kuijpers T, Wright VJ, Levin M, Hibberd ML, Burns JC, on behalf of the US and International Kawasaki Disease Genetics Consortia(includes Goldwater PN as co-author)..   Genome-wide linkage and association mapping identify susceptibility alleles in ABCC4 for Kawasaki disease. J Med Genet (2011). Online First, published on May 13, 2011; doi:10.1136/jmg.2010.086611
  148. 48.  Goldwater PN. Pathological findings in SIDS. Return to pathology; why do a majority of SIDS cases reveal consistent findings? Evidence of a single pathogenetic process? Genetics, preterm and postnatal insults, innate pathogen recognition, infections, and testosterone . . . coinciding contributors to SIDS.Abstracts Soria Moria Meeting.  Scand J Forensic Sci 2011; 1: 40.
  149. 49.  Goldwater PN. A perspective on SIDS pathogenesis. The hypotheses: plausibility and evidence
  150. 49.BMC Medicine 2011, 9:64.  [27 May 2011: Epub ahead of print]. doi:10.1186/1741-7015-9-64  http://www.biomedcentral.com/1741-7015/9/64.
  151. 50.  Highet AR, Berry AM, Bettelheim KA, and Goldwater PN. The frequency of molecular detection of virulence genes encoding cytolysin A, high-pathogenicity island and cytolethal distending toxin of Escherichia coli in cases of sudden infant death syndrome does not differ from that in other infant deaths and healthy infants. J Med Microbiol 2009; 58: 285-289.
  152. 51.  Christopher C Blyth, Emma J Best,  Cheryl A Jones, Clare Nourse, Paul N Goldwater, Andrew J Daley, David Burgner, Guy Henry , Pamela Palasanthiran. Non-tuberculous Mycobacterial Infection in Children: A Prospective National Study.  Pediatr Infect Dis J. 2009 Jul 24. [Epub ahead of print] Volume 28, Number 9, 801–805.
  153. 52.  O’Callaghan ME, Maclennan AH, Gibson CS, McMichael GL, Haan EA, Broadbent JL, Goldwater PN, Dekker GA; for the Australian Collaborative Cerebral Palsy Research Group.      582  Epidemiologic Associations With Cerebral Palsy.  Obstet Gynecol. 2011 Sep;118(3):576-82.
  154. 53.  Willemijn B. Breunis, Sonia Davila, Chisato Shimizu, Toshiaki Oharaseki, Kei Takahashi, Michel van Houdt, Chiea Chuen Khor, Victoria J. Wright, Michael Levin, Jane C Burns, David Burgner, Martin L. Hibberd, Taco W. Kuijpers on behalf of the International Kawasaki Disease Genetics Consortium (includes Goldwater PN as co-author)..  Disruption of vascular homeostasis in Kawasaki Disease patients: Involvement of vascular endothelial growth factor and angiopoietins. Arthritis & Rheumatism 2012; 64(1):306-15. doi: 10.1002/art.33316.
  155. 54.  O'Callaghan M,  MacLennan A, Gibson C,  McMichael G,  Haan E,  Broadbent J,  Goldwater P,  Painter J, Montgomery G,  Dekker G. Fetal and Maternal Candidate SNP Associations with Cerebral Palsy: A Case-Control Study.  Pediatrics 2011 (accepted for publication).
  156. 55.  McMichael G,  Gibson CS, Maclennan AH, Goldwater PN,  Haan EA, Priest K, Dekker GA., writing for the South Australian Cerebral Palsy Research Group.  Cytomegalovirus and Epstein-Barr virus may be associated with some cases of cerebral palsy. The Journal of Maternal-Fetal & Neonatal Medicine 2012 (Epub ahead of print: March 2012)
  157. 56.  Bettelheim KA,  Luke RK J, Johnston N, Pearce JL, Goldwater PN. A Possible Murine Model for Investigation of Pathogenesis of Sudden Infant Death Syndrome. Current Microbiol 2012; 64(3): 276-282. Online First, 16 December 2011. Digital Object Identifier (DOI) 10.1007/s00284-011-0065-4
  158. 57.  Goldwater PN, Bettelheim KA. Treatment  of  Enterohemorrhagic  E.  coli  (EHEC)  infection  and  Hemolytic Uremic Syndrome (HUS). BMC Medicine 2012; 10:12 doi:10.1186/1741-7015-10-12 Published: 2 February 2012 http://www.biomedcentral.com/1741-7015/10/12
  159. 58.  Michael E. O'Callaghan, Alastair H. MacLennan, Catherine S. Gibson, Gai L. McMichael, Eric A. Haan, Jessica L. Broadbent, Paul N. Goldwater, Jodie N. Painter, Grant W. Montgomery, Gus A. Dekker and for the Australian Collaborative Cerebral Research Group. Fetal and Maternal Candidate Single Nucleotide Polymorphism Associations with Cerebral Palsy: A Case-Control Study. Pediatrics; 2012 Feb;129 (2):e414-423. Epub 2012 Jan 30. DOI:10.1542/peds.2011-0739
  160. 59.  Chiea Chuen Khor, Sonia Davila, Willemijn B. Breunis,Yi-Ching Lee, Chisato Shimizu, Victoria J. Wright, Rae SM Yeung, Dennis EK Tan,  et. al., and International Kawasaki Disease Genetics Consortium (includes Goldwater PN as co-author). Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease.  .  Nat Genet. 2011; 43(12): 1241-6.
  161. 60.  Bettelheim KA, Goldwater PN. Shigatoxigenic Escherichia coli (STEC) in Australia: A review. Rev Med Microbiol. In press.

 

Book:

Goldwater, Paul N.  “AIDS : The risk.”  Penguin Books Ltd. l986.

Home > About Us
Back to Top